"Reduced Bleeding Risk: Stopping Aspirin 1 Month After Stent Implant"
A new study suggests that heart attack survivors who have received a stent may benefit from stopping low-dose aspirin a month after the procedure, as it reduces the risk of major and minor bleeding by more than 50% without increasing the likelihood of adverse artery-blocking events. The study, presented at the American College of Cardiology annual meeting and published in The Lancet, tracked outcomes for over 3,400 heart patients and found that stopping aspirin early did not raise the risk of cardiovascular events. The lead author suggests that it may be time to change guidelines and standard clinical practice to no longer treat most heart attack patients with dual antiplatelet therapy for more than a month after stent placement.